This material is provided by Milpharm Ltd as a licence requirement. Please ensure that you are familiar with this material as it contains important safety information.

${pdf_link}$

Prescriber Guide

This material is provided by Milpharm Ltd and forms part of the licence requirement. Please ensure that you are familiar with this material as it contains important safety information

Myfenax

Teva Pharma B.V.

${pdf_link}$

Mycophenolate Mofetil (Myfenax) Guide for Healthcare Providers

This Guide has been designed to highlight the risks to babies associated with exposure to mycophenolate during pregnancy and to minimise the number of pregnancies during treatment with this teratogenic medicinal products. Use this guide during, discussion with the patient to address any questions or concerns the patient may have. Although this Guide presents important information concerning the adverse pregnancy outcomes associated with mycophenolate, please consult the Summary of Product Characteristics (SmPC) for full information on mycophenolate.

${pdf_link}$

Mycophenolate mofetil (Myfenax): risks of miscarriage and birth defects Patient Guide

This guide will help you to remember the information you have discussed with your doctor. Keep it so that you can refer to it again. Also, read the package leaflet supplied with your medicine for full information on mycophenolate mofetil.

Risk Minimisation Materials

Mycophenolate

Rosemont Pharmaceuticals Limited

Tillomed Laboratories Ltd

Mycophenolate mofetil

Aurobindo Pharma - Milpharm Ltd.

Myfenax

Teva Pharma B.V.

You are trying to reach document intended for healthcare professionals only.